Sol-Gel Technologies SLGL
NASDAQ SLGL
$69.96 -0.14 (-0.20%)
As of: Sep 4, 2026 · 3:59 PM EDT

Sol-Gel Technologies (SLGL) Property, Plant & Equipment (Net) (2016 - 2026)

Analysis

Sol-Gel Technologies (SLGL) Property, Plant & Equipment (Net) (2016 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 1.67 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 5.46 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 1.96 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 2.06 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 34.61 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 1.64 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 554.14 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 107.22 Mn
10 Sol-Gel Technologies 194.01 Mn 146.08 Mn - 130,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 130,000.00
Mar 31, 2026 136,000.00
Dec 31, 2025 140,000.00
Sep 30, 2025 145,000.00
Jun 30, 2025 162,000.00
Mar 31, 2025 183,000.00
Dec 31, 2024 202,000.00
Sep 30, 2024 250,000.00
Jun 30, 2024 305,000.00
Mar 31, 2024 366,000.00
Dec 31, 2023 434,000.00
Sep 30, 2023 499,000.00
Jun 30, 2023 569,000.00
Mar 31, 2023 632,000.00
Dec 31, 2022 660,000.00
Sep 30, 2022 728,000.00
Jun 30, 2022 826,000.00
Mar 31, 2022 931,000.00
Dec 31, 2021 1.05 Mn
Sep 30, 2021 1.21 Mn